DMRA · Insider trading · 13F holders · Congress trades
Damora Therapeutics, Inc. (DMRA)
Who is buying and selling DMRA: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $253K
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
DMRA at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 DMRA insider filed 1 open-market purchase worth $253K on SEC Form 4.
- No 13F filer reports DMRA among its 50 largest positions.
- No member of Congress has disclosed a trade in DMRA.
- DMRA last closed at $22.01 on Oct 29, 2026.
DMRA insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 DMRA insider filed 1 open-market purchase worth $253K on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Jarrett Jennifer | Director, President and CEO, Director | Buy | 12,500 | $20.23 | $253K | SEC |
Who owns DMRA? Hedge funds and superinvestors
No 13F filer reports DMRA among its 50 largest positions.
DMRA stock trades by members of Congress
No member of Congress has disclosed a trade in DMRA.
Analysis mentioning DMRA
Posts from the blog that cover Damora Therapeutics, Inc., newest first.
DMRA questions and answers
Are insiders buying DMRA stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 DMRA insider filed 1 open-market purchase worth $253K on SEC Form 4.
Which hedge funds own DMRA?
No 13F filer reports DMRA among its 50 largest positions.
Has Congress traded DMRA?
No member of Congress has disclosed a trade in DMRA.
Cite or share this
Free to use with a link back. The data updates every filing day.